SCHEMBL25628860

SCHEMBL25628860

c1ccc(-c2ccc(N(c3ccc(-c4ccc(-c5ccccc5)c(-c5ccc6ccccc6c5)c4)cc3)c3ccccc3-c3ccccc3)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.39
ESR2 Q92731 3/20 0.39
GSTP1 P09211 1/20 0.39
HSD17B1 P14061 2/20 0.37
HSD17B2 P37059 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
APAF1 O14727 1/20 0.37
NPC1 O15118 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
THRB P10828 1/20 0.37
XBP1 P17861 1/20 0.37
PTBP1 P26599 1/20 0.37
HTT P42858 1/20 0.37
RAB9A P51151 1/20 0.37
GALK1 P51570 1/20 0.37
BLM P54132 1/20 0.37
SMAD3 P84022 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24999202 1.00 ESR1 (0.39) ESR1ESR2GSTP1HSD17B1HSD17B2
SCHEMBL30308523 0.99 ESR1 (0.40) ESR1ESR2GSTP1HSD17B1HSD17B2
SCHEMBL24861936 0.99 ESR1 (0.40) ESR1ESR2GSTP1HSD17B1HSD17B2
SCHEMBL26100672 0.97 HSD17B1 (0.39) ESR1ESR2GSTP1HSD17B1HSD17B2
SCHEMBL25000734 0.96 HSD17B1 (0.40) ESR1ESR2GSTP1HSD17B1HSD17B2
SCHEMBL24748796 0.95 ESR1 (0.37) ESR1ESR2GSTP1HSD17B1HSD17B2
SCHEMBL25628862 0.95 ESR1 (0.37) ESR1ESR2GSTP1HSD17B1HSD17B2
SCHEMBL24999406 0.95 ESR1 (0.37) ESR1ESR2GSTP1HSD17B1HSD17B2
SCHEMBL25000699 0.94 MEN1 (0.37) ESR1ESR2GSTP1HSD17B1HSD17B2
SCHEMBL17811609 0.94 ESR1 (0.43) ESR1ESR2GSTP1HSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230200222-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-22 US disclosed
US-20230200222-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-22 US disclosed
US-11678569-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-06-13 US disclosed
US-11678569-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-06-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230200222-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM ESR1 35/4885ESR2 265/4885GSTP1 2845/4885
US-11678569-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device PIEZO1, LEF1, L1CAM ESR1 35/4885ESR2 265/4885GSTP1 2845/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.